MedTrace Logo

The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

NCT07322653 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-01-07

No results posted yet for this study

Summary

Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia

Conditions

  • Sarcopenia in Elderly
  • Malnourished
  • Protein Supplementation
  • Muscle Mass
  • Physical Function
  • Strength

Interventions

OTHER

MediDrink Platinum+

MediDrink Platinum+ containing novel protein blend SPR-01

OTHER

MediDrink Platinum+ and PeptiStrong

MediDrink Platinum+ containing novel protein blend SPR-01 and PeptiStrong, fava bean protein hydrolysate

Sponsors & Collaborators

  • Medifood Hungary Innovation Kft

    collaborator UNKNOWN

  • Nuritas Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-10
Primary Completion
2026-10-01
Completion
2027-01-02

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07322653 on ClinicalTrials.gov